COVID-19 Bivalent Booster Megastudy

计划入组 2,600,000 人 · 首次发布于 2022 年 11 月 7 日

COVID Booster in Pregnancy and Lactation

计划入组 150 人 · 首次发布于 2022 年 9 月 16 日

Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

计划入组 36 人 · 首次发布于 2025 年 2 月 18 日

mRNA-1273.214

Diphtheria/Tetanus Toxoid combined vaccine (Seqirus)

SII Bivalent

Nuvalent

United States

Bioaster

Belgium

Ivoclar Vivadent Ag

Sweden

FDA Withdraws Original COVID-19 Vaccine Authorization, Focuses on Bivalent Boosters

FDA Authorizes Second Omicron Booster for High-Risk Groups, Simplifies COVID-19 Vaccine Strategy

COVID-19 Boosters Reduce Hospitalization Risk by 29% in Cancer Patients, Large Multi-Center Study Shows